首页 > 最新文献

Parasitologists United Journal最新文献

英文 中文
Investigating the effect of the nitric oxide donor L-arginine on albendazole efficacy in Trichinella spiralis-induced myositis and myocarditis in mice 一氧化氮供体L-精氨酸对阿苯达唑治疗旋毛虫诱导的小鼠肌炎和心肌炎疗效的影响
IF 0.4 Q4 PARASITOLOGY Pub Date : 2022-03-28 DOI: 10.21608/puj.2022.119638.1153
M. Abdeltawab, I. Abdel-Shafi, B. Aboulhoda, Hanaa Wanas, Shimaa Saad El-Din, S. Amer, Alshaimaa Hamed
{"title":"Investigating the effect of the nitric oxide donor L-arginine on albendazole efficacy in Trichinella spiralis-induced myositis and myocarditis in mice","authors":"M. Abdeltawab, I. Abdel-Shafi, B. Aboulhoda, Hanaa Wanas, Shimaa Saad El-Din, S. Amer, Alshaimaa Hamed","doi":"10.21608/puj.2022.119638.1153","DOIUrl":"https://doi.org/10.21608/puj.2022.119638.1153","url":null,"abstract":"","PeriodicalId":41408,"journal":{"name":"Parasitologists United Journal","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47331262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The amazing eradication story and current situation of malaria in Cyprus 塞浦路斯令人惊叹的疟疾根除故事和现状
IF 0.4 Q4 PARASITOLOGY Pub Date : 2022-03-24 DOI: 10.21608/puj.2022.118294.1149
Emrah Guler, M. Guvenir, K. Suer
{"title":"The amazing eradication story and current situation of malaria in Cyprus","authors":"Emrah Guler, M. Guvenir, K. Suer","doi":"10.21608/puj.2022.118294.1149","DOIUrl":"https://doi.org/10.21608/puj.2022.118294.1149","url":null,"abstract":"","PeriodicalId":41408,"journal":{"name":"Parasitologists United Journal","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44297691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review on The Antiparasitic Properties of Inorganic Silver Nanoparticles (AgNps) 无机纳米银抗寄生性能研究进展
IF 0.4 Q4 PARASITOLOGY Pub Date : 2022-02-28 DOI: 10.21608/puj.2022.108173.1145
M. Gomaa
{"title":"A Review on The Antiparasitic Properties of Inorganic Silver Nanoparticles (AgNps)","authors":"M. Gomaa","doi":"10.21608/puj.2022.108173.1145","DOIUrl":"https://doi.org/10.21608/puj.2022.108173.1145","url":null,"abstract":"","PeriodicalId":41408,"journal":{"name":"Parasitologists United Journal","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44301750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Efficacy of coconut oil as a therapeutic agent with potential anti-cancer activity in immunosuppressed mice with cryptosporidiosis: Parasitological, histopathological and immunohistochemical studies 椰子油对隐孢子虫病免疫抑制小鼠的潜在抗癌作用:寄生虫学、组织病理学和免疫组织化学研究
IF 0.4 Q4 PARASITOLOGY Pub Date : 2022-02-01 DOI: 10.21608/puj.2022.95720.1133
H. Abdelmaksoud, T. Aboushousha, A. Ashkar
{"title":"Efficacy of coconut oil as a therapeutic agent with potential anti-cancer activity in immunosuppressed mice with cryptosporidiosis: Parasitological, histopathological and immunohistochemical studies","authors":"H. Abdelmaksoud, T. Aboushousha, A. Ashkar","doi":"10.21608/puj.2022.95720.1133","DOIUrl":"https://doi.org/10.21608/puj.2022.95720.1133","url":null,"abstract":"","PeriodicalId":41408,"journal":{"name":"Parasitologists United Journal","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49100021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Seropositivity of toxoplasmosis among hemodialysis children patients at Zagazig University Pediatrics Hospital, Egypt 埃及扎加齐格大学儿科医院血液透析患儿弓形虫病血清阳性分析
IF 0.4 Q4 PARASITOLOGY Pub Date : 2022-02-01 DOI: 10.21608/puj.2022.105855.1144
M. Sarhan
{"title":"Seropositivity of toxoplasmosis among hemodialysis children patients at Zagazig University Pediatrics Hospital, Egypt","authors":"M. Sarhan","doi":"10.21608/puj.2022.105855.1144","DOIUrl":"https://doi.org/10.21608/puj.2022.105855.1144","url":null,"abstract":"","PeriodicalId":41408,"journal":{"name":"Parasitologists United Journal","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42896039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Burden of intestinal parasites in a cohort of diarrheic Egyptian children: Predominance of Cryptosporidium using nested PCR assay 埃及腹泻儿童肠道寄生虫的负担:使用套式PCR检测隐孢子虫的优势
IF 0.4 Q4 PARASITOLOGY Pub Date : 2022-01-30 DOI: 10.21608/puj.2022.113697.1147
Ayman Abdel-Maogod, Ahmed M. S. Bayoumy, K. Hassan, M. El-Faramawy, A. Ibrahim, A. El-Badry
{"title":"Burden of intestinal parasites in a cohort of diarrheic Egyptian children: Predominance of Cryptosporidium using nested PCR assay","authors":"Ayman Abdel-Maogod, Ahmed M. S. Bayoumy, K. Hassan, M. El-Faramawy, A. Ibrahim, A. El-Badry","doi":"10.21608/puj.2022.113697.1147","DOIUrl":"https://doi.org/10.21608/puj.2022.113697.1147","url":null,"abstract":"","PeriodicalId":41408,"journal":{"name":"Parasitologists United Journal","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2022-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44267608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug resistance, recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. I. Drug resistance 寄生虫病的耐药性、潜在药物靶点鉴定和新药开发的最新进展。一、耐药性
IF 0.4 Q4 PARASITOLOGY Pub Date : 2021-12-06 DOI: 10.21608/puj.2021.103436.1141
S. Abaza
{"title":"Drug resistance, recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. I. Drug resistance","authors":"S. Abaza","doi":"10.21608/puj.2021.103436.1141","DOIUrl":"https://doi.org/10.21608/puj.2021.103436.1141","url":null,"abstract":"","PeriodicalId":41408,"journal":{"name":"Parasitologists United Journal","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2021-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46286101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Evaluation of potential prophylactic and therapeutic effect of azoximer bromide (polyoxidonium) on experimental cryptosporidiosis in immunocompromised mice 偶氮莫莫溴(多氧化铵)对免疫功能低下小鼠隐孢子虫病潜在预防和治疗作用的评价
IF 0.4 Q4 PARASITOLOGY Pub Date : 2021-12-01 DOI: 10.21608/puj.2021.102944.1140
A. Atia, M. El Sobky, N. Harba, Rasha Elmehy, Dina Allam, Noha Abou Hussien
Background: Considering the broad burden of cryptosporidiosis, there is still a limited choice of curative treatments. Nitazoxanide (NTZ) is the only anti-cryptosporidial agent currently available. Unfortunately, it showed low efficacy in children and AIDS patients. Accordingly, supplementation with immune-stimulation drugs is feasible. Objective: To demonstrate the prophylactic immunomodulating effect of the immunostimulant Azoximer Bromide (AZB) and evaluate its potential therapeutic efficacy when combined with NTZ, for treatment of cryptosporidiosis in experimentally immunosuppressed mice. Material and Methods: Ninety laboratory bred Swiss albino male mice were immunosuppressed and divided into three groups (30 mice each): control group (GI); prophylactic group, AZB treated then infected (GII); therapeutic group, oocysts infected then treated (GIII). Each group was divided equally into 3 sub-groups (10 mice each). Controls included: GIa, non-infected control negative; GIb, oocysts infected control positive; GIc, non-infected AZB treated drug control. Prophylactic subgroups included: GIIa, received AZB booster injection; GIIb, NTZ treated; GIIc, AZB+ NTZ treated. Therapeutic subgroups included: GIIIa, AZB treated; GIIIb, NTZ treated; GIIIc, AZB+NTZ treated. Oocysts shedding and the efficacy percentage of each drug were calculated. Other parameters used included histopathological examination and immunohistochemical assessment of small intestine and lung tissues, and serum analyses for biochemical, immunological and antioxidants evaluations. Results: The prophylactic effect of AZB alone and its therapeutic effect when combined with NTZ gave the best reduction rate of oocyst shedding with marked improvement in histopathological features, and significantly reduced hepatic enzymes. Additionally, AZB enhanced the mice immunogenicity with significant upregulation of interleukin (IL)-1β, IL-6, tumor necrotic factor (TNF)-α and interferon (INF)-γ; overexpression of CD3 protein in pulmonary tissue, and significant elevation of antioxidant activity. Conclusion: A powerful effect was achieved by AZB when administered with NTZ for treatment of experimental cryptosporidiosis with elicited high immune response of immunosuppressed mice. PARASITOLOGISTS UNITED JOURNAL 294 and plays an important role in both innate and adaptive immune responses[8]. In the acute phase of infection, Cryptosporidium spp. sporozoites induce the production of IL-12 by macrophages and dendritic cells[9] that acts synergistically with IL-18 and TNF-α to activate natural killer (NK) cells[10]. In addition, TNF-α prevents the establishment of Cryptosporidium spp. infection in enterocytes[11]. Besides, other proinflammatory cytokines (IL-1, IL-6) released by multiple immunocompetent cells exert protective effect[12]. Adequate T helper cell responses are critical for hosts to orchestrate enough defensive mechanisms for infection control. This suggests a major role for host immune factors i
背景:考虑到隐孢子虫病的广泛负担,仍然有有限的治疗选择。Nitazoxanide (NTZ)是目前唯一可用的抗隐孢子虫药物。不幸的是,它对儿童和艾滋病患者的疗效很低。因此,补充免疫刺激药物是可行的。目的:探讨免疫刺激剂偶氮唑海默溴化剂(Azoximer Bromide, AZB)对实验性免疫抑制小鼠隐孢子虫病的预防免疫调节作用,并评价其联合NTZ治疗隐孢子虫病的潜在疗效。材料与方法:对90只实验室繁殖的瑞士白化病雄性小鼠进行免疫抑制,随机分为3组(每组30只):对照组(GI组);预防组,AZB先治疗后感染(GII);治疗组,卵囊感染后再治疗(GIII)。每组平均分为3个亚组(每组10只)。对照组包括:GIa,非感染阴性对照;GIb,卵囊感染对照阳性;GIc,非感染AZB治疗药物控制。预防亚组包括:GIIa组,接受AZB加强注射;GIIb、NTZ治疗;GIIc、AZB+ NTZ处理。治疗亚组包括:GIIIa、AZB治疗;GIIIb、NTZ处理;GIIIc、AZB+NTZ处理。计算卵囊脱落率及各药物的有效率。其他参数包括小肠和肺组织的组织病理学检查和免疫组织化学评估,以及生化、免疫和抗氧化剂评估的血清分析。结果:AZB单用的预防作用和与NTZ合用的治疗效果均以卵囊脱落减减率最佳,组织病理特征明显改善,肝酶明显降低。此外,AZB通过显著上调白细胞介素(IL)-1β、IL-6、肿瘤坏死因子(TNF)-α和干扰素(INF)-γ,增强小鼠的免疫原性;肺组织中CD3蛋白过表达,抗氧化活性显著升高。结论:AZB与NTZ联合用药对实验性隐孢子虫病有较强的治疗作用,可引起免疫抑制小鼠较高的免疫应答。它在先天和适应性免疫反应中都起重要作用[b]。在感染的急性期,隐孢子虫孢子体诱导巨噬细胞和树突状细胞[9]产生IL-12,与IL-18和TNF-α协同作用,激活自然杀伤细胞[10]。此外,TNF-α可阻止隐孢子虫感染在肠细胞[11]中建立。此外,多种免疫活性细胞释放的其他促炎因子(IL-1、IL-6)也发挥保护作用[12]。充分的T辅助细胞反应对于宿主协调足够的防御机制来控制感染至关重要。这提示宿主免疫因子在控制隐孢子虫病[13]中起重要作用。据报道,隐孢子虫诱导的氧化应激可引起小鼠[14]和猪[14]的组织损伤。因此,减少氧化应激使宿主能够维持一个可行的免疫组合,能够根除病原体并减少宿主组织损伤[16]。总抗氧化能力(TAC)和丙二醛(MDA)浓度的变化是评估氧化应激的有价值的生物标志物。目前批准的治疗药物,NTZ和paromomycin,对免疫功能低下的个体的作用有限。几种药物和联合用药如利福昔明和阿奇霉素也对隐孢子虫病进行了研究,结果不令人满意。有限的治疗选择使得迫切需要开发新的抗寄生虫药物。为此,额外使用非特异性免疫刺激药物是一种合理的选择,可以增强机体对寄生虫感染的抵抗力。偶氮氧默溴化(Polyoxidonium®)是一类新的杂链脂肪族多胺类具有生理活性的化合物。它是一种高分子量的合成免疫调节剂药物,可增加对局部和全身感染的抵抗力,可用于治疗病毒感染。值得一提的是,AZB在俄罗斯被批准作为刺激抗体产生的疫苗佐剂药物。根据对约5000万名接种者的分析,商业流感疫苗中的AZB与抗原复合物显示出高安全性。此外,它还用于支气管哮喘[23]、慢性复发性单纯疱疹感染[24]、肺炎[25]、肾盂肾炎[26]、复发性泌尿生殖道衣原体感染[27]和特应性皮炎[28]等多种疾病。公认的AZB的免疫调节作用在免疫抑制患者[29]中引发或放大免疫反应,并被认为是治疗寄生虫病[29]的免疫调节剂。 控制免疫缺陷个体隐孢子虫腹泻不良后果的困难促使我们考虑AZB与NTZ的可能保护和/或治疗价值。使用AZB可能会阻止隐孢子虫感染免疫功能低下宿主的暴发性结果和/或改善免疫反应。本研究旨在评价免疫刺激剂AZB联合NTZ对隐孢子虫病免疫抑制小鼠的预防和治疗作用,以及它们的双重作用。材料与方法本实验病例对照研究于2019年4月开始,于2020年5月完成。该研究是在梅努菲亚大学医学院医学寄生虫学和病理学系实验室进行的。实验动物:选用90只瑞士白化雄性实验室小鼠,体重20±3 gm。小鼠来自埃及吉萨Theodor Bilharze研究所(TBRI)血吸虫生物供应计划(SBSP),饲养于TBRI动物舍标准饲养条件下。小鼠在隐孢子虫感染前适应实验条件10天。在最佳条件下,将小鼠分别饲养在不同的笼子中。私人实验室的老鼠颗粒作为食物和水也很容易获得。在此期间,对所有小鼠进行粪便检查,以确保它们没有寄生虫。研究设计:将90只小鼠免疫抑制14 d后分为三组(I、II、III),每组平均分为a、b、c三亚组,每亚组10只(表1)。存活小鼠于颈椎脱位[32]感染后第30天处死。通过寄生虫学、组织病理学、免疫组织化学和免疫学检查评价药物对小鼠隐孢子虫病的治疗效果。小鼠免疫抑制:所有小鼠在口服隐孢子虫卵囊前连续14天口服合成皮质类固醇(地塞酮片0.5 mg, Al Kahira Pharmaceutical, and Chemical Industries Company, Egypt),剂量为25 μg/gm体重/d[33,34]。小鼠感染:从自然感染的小牛[35]粪便中收集隐孢子虫卵囊,用改良Zeihl - Neelsen (MZN)染色[36]鉴定。卵囊在Sheather 's sugar溶液中浮法浓缩,沉淀物收集并保存在2.5%重铬酸钾溶液中,温度4°C[37]。感染前将卵囊浓缩在实验隐孢子虫病Atia等人295 PBS溶液中,用血细胞计进行计数。用结核菌素注射器[38]在小鼠食管内感染30003500个卵囊。每天观察各组,记录整个试验期间的死亡率。药物方案:NTZ由Copad Pharma(埃及贸易和制药工业,Obour City,埃及开罗)以“Cryptonaz®”60 ml混悬液的形式提供,浓度为100 mg/5 ml。从第15 dpi开始,以500 mg/kg的剂量口服iib、iic、iib和iic亚组小鼠,连续5天。剂量是根据佩吉特和巴恩斯表计算的。AZB由俄罗斯Cosmic Nootropic公司以“Polyoxidonium®”6 mg冻干液的形式供应,用于制备注射用溶液。预防组以0.2 ml 0.9% NaCl注射IM,剂量为0.004 mg/只,间隔48 h,治疗组(IIIa和IIIc亚组)从第15 dpi[31]开始以相同剂量注射。感染的寄生虫学评价:实验最后一天(第30 dpi),每只小鼠单独收集新鲜粪球,分别标记卵囊计数,MZN染色法检测,计算隐孢子虫卵囊脱落[32]。涂片用实验室显微镜和x40和x100物镜检查。计算10个高倍场(HPFs)中隐孢子虫卵囊的数量,并估计其数量为平均值。每种药物的减少百分比采用公式计算:疗效(%)=[(感染未治疗组的平均值(G b)所有感染治疗组(预防或治疗)的平均值/感染未治疗组的平均值]x100[39]。组织病理学检查:取每只小鼠回肠末端1 cm及全肺组织,10%中性福尔马林固定。回肠和肺组织石蜡包埋,切片,载玻片,二甲苯浸泡,分级乙醇溶液脱水,苏木精和伊红(HE)[40]染色。染色切片评估组织的任
{"title":"Evaluation of potential prophylactic and therapeutic effect of azoximer bromide (polyoxidonium) on experimental cryptosporidiosis in immunocompromised mice","authors":"A. Atia, M. El Sobky, N. Harba, Rasha Elmehy, Dina Allam, Noha Abou Hussien","doi":"10.21608/puj.2021.102944.1140","DOIUrl":"https://doi.org/10.21608/puj.2021.102944.1140","url":null,"abstract":"Background: Considering the broad burden of cryptosporidiosis, there is still a limited choice of curative treatments. Nitazoxanide (NTZ) is the only anti-cryptosporidial agent currently available. Unfortunately, it showed low efficacy in children and AIDS patients. Accordingly, supplementation with immune-stimulation drugs is feasible. Objective: To demonstrate the prophylactic immunomodulating effect of the immunostimulant Azoximer Bromide (AZB) and evaluate its potential therapeutic efficacy when combined with NTZ, for treatment of cryptosporidiosis in experimentally immunosuppressed mice. Material and Methods: Ninety laboratory bred Swiss albino male mice were immunosuppressed and divided into three groups (30 mice each): control group (GI); prophylactic group, AZB treated then infected (GII); therapeutic group, oocysts infected then treated (GIII). Each group was divided equally into 3 sub-groups (10 mice each). Controls included: GIa, non-infected control negative; GIb, oocysts infected control positive; GIc, non-infected AZB treated drug control. Prophylactic subgroups included: GIIa, received AZB booster injection; GIIb, NTZ treated; GIIc, AZB+ NTZ treated. Therapeutic subgroups included: GIIIa, AZB treated; GIIIb, NTZ treated; GIIIc, AZB+NTZ treated. Oocysts shedding and the efficacy percentage of each drug were calculated. Other parameters used included histopathological examination and immunohistochemical assessment of small intestine and lung tissues, and serum analyses for biochemical, immunological and antioxidants evaluations. Results: The prophylactic effect of AZB alone and its therapeutic effect when combined with NTZ gave the best reduction rate of oocyst shedding with marked improvement in histopathological features, and significantly reduced hepatic enzymes. Additionally, AZB enhanced the mice immunogenicity with significant upregulation of interleukin (IL)-1β, IL-6, tumor necrotic factor (TNF)-α and interferon (INF)-γ; overexpression of CD3 protein in pulmonary tissue, and significant elevation of antioxidant activity. Conclusion: A powerful effect was achieved by AZB when administered with NTZ for treatment of experimental cryptosporidiosis with elicited high immune response of immunosuppressed mice. PARASITOLOGISTS UNITED JOURNAL 294 and plays an important role in both innate and adaptive immune responses[8]. In the acute phase of infection, Cryptosporidium spp. sporozoites induce the production of IL-12 by macrophages and dendritic cells[9] that acts synergistically with IL-18 and TNF-α to activate natural killer (NK) cells[10]. In addition, TNF-α prevents the establishment of Cryptosporidium spp. infection in enterocytes[11]. Besides, other proinflammatory cytokines (IL-1, IL-6) released by multiple immunocompetent cells exert protective effect[12]. Adequate T helper cell responses are critical for hosts to orchestrate enough defensive mechanisms for infection control. This suggests a major role for host immune factors i","PeriodicalId":41408,"journal":{"name":"Parasitologists United Journal","volume":"1 1","pages":""},"PeriodicalIF":0.4,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42254334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Perceptions on therapeutic modalities regarding the virulence and immunity of cutaneous leishmaniasis 关于皮肤利什曼病毒力和免疫的治疗方式的看法
IF 0.4 Q4 PARASITOLOGY Pub Date : 2021-12-01 DOI: 10.21608/puj.2021.95583.1132
E. E. El Saftawy, Ahmed B. Hamed, A. Sameh, R. Sarhan
Despite the wide variety of Leishmania spp. virulence, the present repertoire of drugs has limited effects, showing increased resistance. The effect depends on host immune factors which differ between immunocompetent and immunocompromised patients, and among various clinical forms of the disease. Recently, metallocomplexes have been increasingly shown to be potent delivery systems for conventional treatments. Additionally, lasers were suggested as an efficacious treatment tool due to their potentials in the clinical applications and resolution of the disease. This review suggests that the promising leishmanicidal activity of the metallocomplexes and laser treatment comprise a new hopeful alternative in the search for definitive cutaneous leishmaniasis (CL) cure. PARASITOLOGISTS UNITED JOURNAL 230 subsets of CD4+ and CD8+ T cells, and their cytokines profiles[16] as well as the triggered production of reactive oxygen species (ROS) and nitric oxide (NO) in mouse macrophages[17]. Interestingly, co-treatment of infected macrophages with exogenous IFN-γ and TNF-α can considerably destroy the parasites and lead to SbV accumulation[16]. It is also organ-dependent, being more efficient in the liver than the spleen or bone marrow[18] due to the pharmacokinetic profile of the drug[19]. Side effects and drug resistance: Injection pain and systemic side effects have been recorded[20]. Sodium antimony gluconate despite being described with minor side effects at the therapeutic doses[6], has cumulative effects such as acute interstitial nephritis and cardiotoxicity during or after a long course of drug administration[20,21]. Dangerous cardiotoxicity features occur in 50% of the patients and include a concave ST segment, corrected QT interval prolongation followed by multiple ventricular ectopic foci, then ventricular tachycardia, torsade de pointes, ventricular fibrillation[15] and diminution in the height of T waves and T-wave inversion[22]. This was attributed to the high affinity for sulfhydryl groups that affect the calcium channels[23]. In accordance, it has been found to prolong the action potential of ventricular myocytes in guinea pigs at therapeutic doses with developed QT prolongation and life-threatening arrhythmias[24]. Higher doses of SbV were found to be associated with increased pancreatitis[25] especially in AIDS patients[26]. In New World CL, elevation of pancreatic and liver enzymes was also observed in a study at the dose of 20 mg/ kg/d for 20 d[27]. In Brazil, a higher frequency of skin reactions was observed in some patients with CL treated with meglumine antimoniate, due to the greater concentrations of total and trivalent antimony, lead, cadmium, arsenic and lower values of osmolarity and pH[28]. These effects can lead to cessation of treatment before attaining curative levels[29]. Additionally, the emergence of parasite resistance against SbIII was recorded in some areas suffering from VL e.g., India[30-32]. Drug resistance was suggeste
尽管利什曼原虫的毒力种类繁多,但目前的药物效果有限,耐药性增加。这种影响取决于宿主免疫因素,免疫功能正常和免疫功能低下的患者以及各种临床形式的疾病的宿主免疫因素不同。最近,金属配合物已越来越多地被证明是用于常规治疗的有效递送系统。此外,由于激光在临床应用和疾病解决方面的潜力,激光被认为是一种有效的治疗工具。这篇综述表明,金属配合物和激光治疗具有很好的杀利什曼病活性,为寻找最终的皮肤利什曼原虫病(CL)治疗方法提供了一种新的有希望的选择。寄生虫学联合杂志230 CD4+和CD8+T细胞亚群及其细胞因子谱[16],以及小鼠巨噬细胞中活性氧(ROS)和一氧化氮(NO)的触发产生[17]。有趣的是,用外源性IFN-γ和TNF-α联合治疗感染的巨噬细胞可以显著破坏寄生虫并导致SbV积累[16]。它也是器官依赖性的,由于药物的药代动力学特征,在肝脏中比在脾脏或骨髓中更有效[18]。副作用和耐药性:记录了注射疼痛和全身副作用[20]。葡萄糖酸锑钠尽管被描述为在治疗剂量下有轻微副作用[6],但在长期给药期间或之后具有累积效应,如急性间质性肾炎和心脏毒性[20,21]。50%的患者出现危险的心脏毒性特征,包括ST段凹陷、校正的QT间期延长,随后出现多个心室异位灶,然后是室性心动过速、尖端扭转性心动过缓、心室颤动[15]以及T波高度降低和T波倒置[22]。这归因于对影响钙通道的巯基的高亲和力[23]。据此,已发现在治疗剂量下延长豚鼠心室肌细胞的动作电位,并出现QT延长和危及生命的心律失常[24]。研究发现,较高剂量的SbV与胰腺炎增加有关[25],尤其是在艾滋病患者中[26]。在新世界CL中,在一项研究中,在20 mg/kg/d的剂量下持续20天,也观察到胰腺和肝脏酶的升高[27]。在巴西,由于总锑和三价锑、铅、镉、砷的浓度较高,渗透压和pH值较低,一些接受锑酸葡胺治疗的CL患者的皮肤反应频率较高[28]。这些影响可能导致在达到治疗水平之前停止治疗[29]。此外,在一些患有VL的地区,如印度,记录到寄生虫对SbIII的耐药性出现[30-32]。耐药性被认为与参与药物流出的寄生虫蛋白有关,例如水甘油蛋白-1[33]和利什曼原虫三磷酸腺苷(ATP)结合盒-G2(LABCG2)[34]。墨西哥乳杆菌对SbV的敏感性低于巴西乳杆菌,而小鼠巨噬细胞中的主要乳杆菌无鞭毛虫对SSG的敏感性低于多诺瓦尼乳杆菌[35]。然而,由于缺乏疫苗和有限的治疗方法,它被认为是一线治疗[36]。2.戊脒的剂量和给药途径:戊脒肌肉注射剂量为4 mg/kg,血浆峰值浓度约为0.5 mg/l,在1小时内达到;并且由于药物的广泛组织结合,在给药后6-8周内继续在血浆中鉴定[37]。作用机制:它会抑制活性转运系统和线粒体拓扑异构酶II,最终摧毁寄生虫[38]。副作用和耐药性:药物在肾脏积聚引起的肾小管毒性[39]。此外,据信,对胰岛细胞的直接细胞毒性作用会导致低血糖(通过初始胰岛素释放),然后是高血糖(通过细胞裂解和胰岛素消耗)[40]。其他不良反应包括低血压和异常图1。显示SbIII对寄生虫衍生的分子靶标作用的范例:(1)TR系统。(2) 锌指印蛋白。(3) 腺嘌呤和脱氧核苷复合物的协同作用。IFN-γ:干扰素-γ;TR:锥虫腈还原酶;Gp63:糖蛋白63;ROS:活性氧。E.Elsaftawy绘制。巨噬细胞ROS++
{"title":"Perceptions on therapeutic modalities regarding the virulence and immunity of cutaneous leishmaniasis","authors":"E. E. El Saftawy, Ahmed B. Hamed, A. Sameh, R. Sarhan","doi":"10.21608/puj.2021.95583.1132","DOIUrl":"https://doi.org/10.21608/puj.2021.95583.1132","url":null,"abstract":"Despite the wide variety of Leishmania spp. virulence, the present repertoire of drugs has limited effects, showing increased resistance. The effect depends on host immune factors which differ between immunocompetent and immunocompromised patients, and among various clinical forms of the disease. Recently, metallocomplexes have been increasingly shown to be potent delivery systems for conventional treatments. Additionally, lasers were suggested as an efficacious treatment tool due to their potentials in the clinical applications and resolution of the disease. This review suggests that the promising leishmanicidal activity of the metallocomplexes and laser treatment comprise a new hopeful alternative in the search for definitive cutaneous leishmaniasis (CL) cure. PARASITOLOGISTS UNITED JOURNAL 230 subsets of CD4+ and CD8+ T cells, and their cytokines profiles[16] as well as the triggered production of reactive oxygen species (ROS) and nitric oxide (NO) in mouse macrophages[17]. Interestingly, co-treatment of infected macrophages with exogenous IFN-γ and TNF-α can considerably destroy the parasites and lead to SbV accumulation[16]. It is also organ-dependent, being more efficient in the liver than the spleen or bone marrow[18] due to the pharmacokinetic profile of the drug[19]. Side effects and drug resistance: Injection pain and systemic side effects have been recorded[20]. Sodium antimony gluconate despite being described with minor side effects at the therapeutic doses[6], has cumulative effects such as acute interstitial nephritis and cardiotoxicity during or after a long course of drug administration[20,21]. Dangerous cardiotoxicity features occur in 50% of the patients and include a concave ST segment, corrected QT interval prolongation followed by multiple ventricular ectopic foci, then ventricular tachycardia, torsade de pointes, ventricular fibrillation[15] and diminution in the height of T waves and T-wave inversion[22]. This was attributed to the high affinity for sulfhydryl groups that affect the calcium channels[23]. In accordance, it has been found to prolong the action potential of ventricular myocytes in guinea pigs at therapeutic doses with developed QT prolongation and life-threatening arrhythmias[24]. Higher doses of SbV were found to be associated with increased pancreatitis[25] especially in AIDS patients[26]. In New World CL, elevation of pancreatic and liver enzymes was also observed in a study at the dose of 20 mg/ kg/d for 20 d[27]. In Brazil, a higher frequency of skin reactions was observed in some patients with CL treated with meglumine antimoniate, due to the greater concentrations of total and trivalent antimony, lead, cadmium, arsenic and lower values of osmolarity and pH[28]. These effects can lead to cessation of treatment before attaining curative levels[29]. Additionally, the emergence of parasite resistance against SbIII was recorded in some areas suffering from VL e.g., India[30-32]. Drug resistance was suggeste","PeriodicalId":41408,"journal":{"name":"Parasitologists United Journal","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42628505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Impact of H. Pylori and/or Toxoplasma Gondii Infection on Recurrence of Gastritis and Gastric ulcer 幽门螺杆菌和/或弓形虫感染对胃炎和胃溃疡复发的影响
IF 0.4 Q4 PARASITOLOGY Pub Date : 2021-11-21 DOI: 10.21608/puj.2021.96310.1134
Waleed E. Elawamy, Amany A Ghazy, Ahmed Haydara, A. Taha
{"title":"The Impact of H. Pylori and/or Toxoplasma Gondii Infection on Recurrence of Gastritis and Gastric ulcer","authors":"Waleed E. Elawamy, Amany A Ghazy, Ahmed Haydara, A. Taha","doi":"10.21608/puj.2021.96310.1134","DOIUrl":"https://doi.org/10.21608/puj.2021.96310.1134","url":null,"abstract":"","PeriodicalId":41408,"journal":{"name":"Parasitologists United Journal","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2021-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46857731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Parasitologists United Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1